Clinical Trial Update: Drug Interaction Study of GBT440 With Caffeine, S-warfarin, Omeprazole, and Midazolam in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study assessing potential drug interactions between GBT440 (voxelotor) and caffeine, S-warfarin, omeprazole, and midazolam in healthy subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Caffeine (caffeine)
• Midazolam (Midazolam)
• Omeprazole (Omeprazole)
• Oxbryta (voxelotor)
• S-warfarin (S-warfarin)

Snippet

Sponsor: Global Blood Therapeutics | Conditions: Sickle Cell Disease | Phase 1 | Status: COMPLETED